La Merie Business Intelligence publishes two independent newsletters with a focus on biopharmaceutical research and development. Both newsletters contain brief abstracts of company press releases about preclinical & clinical studies, regulatory updates and related business news. Hyperlinks are provided leading to the original press releases posted in www.pipelinereview.com

La Merie Daily is published each working day with a selection of R&D news across all therapeutic areas, of related business deals or M&A transactions and of corporate news. The newsletter in HTML format is sent by e-mail and contains a summary of concise titles in a preview mode with links to the each abstract in the newsletter and a reference to the original press release posted in the website PipelineReview.com.

La Merie Biologics is published each Monday as a PDF document and sent by e-mail. This weekly newsletter is focused on antibodies, proteins & peptides, gene therapy, RNA and cell therapy, vaccines, biogenerics and related business. It contains brief abstracts of preclinical & clinical studies, regulatory updates and company news of the previous week, but for biologics only. A hyperlink at the end of each abstract allows access to the original press release posted in the website PipelineReview.com.

Read past editions of La Merie Biologics